1. Seroprevalence Survey of Anti-SARS-CoV-2 Antibodies in a Population of Emilia-Romagna Region, Northern Italy
- Author
-
Stefania Paduano, Pasquale Galante, Nausicaa Berselli, Luca Ugolotti, Alberto Modenese, Alessandro Poggi, Marcella Malavolti, Sara Turchi, Isabella Marchesi, Roberto Vivoli, Paola Perlini, Rossana Bellucci, Fabriziomaria Gobba, Marco Vinceti, Tommaso Filippini, and Annalisa Bargellini
- Subjects
Male ,SARS-CoV-2 ,Health, Toxicology and Mutagenesis ,Health Personnel ,Public Health, Environmental and Occupational Health ,COVID-19 ,Middle Aged ,occupational risk ,seroprevalence ,waves ,workers ,Antibodies, Viral ,Cross-Sectional Studies ,Italy ,Seroepidemiologic Studies ,Humans ,Female ,Pandemics ,Aged - Abstract
Italy was the first Western European country to be severely hit by the COVID-19 pandemic. Variations in seroprevalence rates were reported according to geographical and temporal differences of previous surveys, as well as depending on demographic and occupational factors. In this cross-sectional study, we evaluated the prevalence of anti-SARS-CoV-2 antibodies in a population of the Emilia-Romagna region in Northern Italy after the first wave in the period from 26 September 2020–26 March 2021. We included 5128 subjects who voluntarily underwent serological tests to determine anti-SARS-CoV-2 antibody positivity, including both self-referred individuals (24.2%) and workers adhering to company screening programs (76.8%). Overall, seroprevalence was 11.3%, higher in self-referred (13.8%) than employed-referred (10.5%) individuals. A slightly higher seroprevalence emerged in women compared to men (12.3% and 10.7%), as well as in the extreme age categories (18.6% for 60–69 years, 18.0% for ≥70 years, and 17.1% for
- Published
- 2022
- Full Text
- View/download PDF